Our findings demonstrate that combined p16 and MTAP immunostains correctly detect CDKN2A homozygous deletion in PXA, while MTAP expression alone shows reduced sensitivity. This evidence concerns the gene MTAP and pleomorphic xanthoastrocytoma.